SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
小可
Lv3
300 积分
2023-03-26 加入
最近求助
最近应助
互助留言
Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE)
3个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
5个月前
已完结
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+breast cancer: a plain language summary of the PHERGain study
5个月前
已完结
Molecular Subtypes and Local-Regional Control of Breast Cancer
5个月前
已完结
Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer
5个月前
已完结
Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer
5个月前
已完结
De-escalating treatment in the adjuvant setting in HER2-positive breast cancer
5个月前
已完结
Molecular characteristics and prognosis of breast cancer patients with different level of HER2 positivity after adjuvant and neoadjuvant chemotherapy
5个月前
已完结
Ki67 assessment in breast cancer: an update
5个月前
已完结
A Real-World Data Retrospective Cohort Study of HER2-positive, Early-Stage Breast Cancer in Patients 70 Years of Age or Older: Natural History, Treatment Patterns, and Outcomes
5个月前
已完结
没有进行任何应助
文件为sup,不是求助文章
5个月前
感谢
11个月前
感谢
11个月前
感谢
11个月前
帮大忙了,感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论